Your browser doesn't support javascript.
loading
Pazopanib for treatment of advanced malignant and dedifferentiated solitary fibrous tumour: a multicentre, single-arm, phase 2 trial.
Martin-Broto, Javier; Stacchiotti, Silvia; Lopez-Pousa, Antonio; Redondo, Andres; Bernabeu, Daniel; de Alava, Enrique; Casali, Paolo G; Italiano, Antoine; Gutierrez, Antonio; Moura, David S; Peña-Chilet, Maria; Diaz-Martin, Juan; Biscuola, Michele; Taron, Miguel; Collini, Paola; Ranchere-Vince, Dominique; Garcia Del Muro, Xavier; Grignani, Giovanni; Dumont, Sarah; Martinez-Trufero, Javier; Palmerini, Emanuela; Hindi, Nadia; Sebio, Ana; Dopazo, Joaquin; Dei Tos, Angelo Paolo; LeCesne, Axel; Blay, Jean-Yves; Cruz, Josefina.
Afiliação
  • Martin-Broto J; Department of Medical Oncology, University Hospital Virgen del Rocío, Sevilla, Spain; Institute of Biomedicine of Sevilla, Sevilla, Spain. Electronic address: jmartin@mustbesevilla.org.
  • Stacchiotti S; Adult Mesenchymal and Rare Tumor Unit, Department of Cancer Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Lopez-Pousa A; Department of Medical Oncology, Sant Pau Hospital, Barcelona, Spain.
  • Redondo A; Department of Medical Oncology, University Hospital La Paz, Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain.
  • Bernabeu D; Musculoskeletal Imaging Section, University Hospital La Paz, Madrid, Spain.
  • de Alava E; Department of Pathology, University Hospital Virgen del Rocío, Sevilla, Spain; Institute of Biomedicine of Sevilla, Sevilla, Spain; CIBERONC, Madrid, Spain.
  • Casali PG; Adult Mesenchymal and Rare Tumor Unit, Department of Cancer Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Italiano A; Department of Oncology, Institut Bergonié, Bordeaux, France.
  • Gutierrez A; Department of Hematology, University Hospital Son Espases, Palma, Balearic Islands, Spain.
  • Moura DS; Institute of Biomedicine of Sevilla, Sevilla, Spain.
  • Peña-Chilet M; Clinical Bioinformatics Area, Fundación Progreso y Salud, University Hospital Virgen del Rocío, Sevilla, Spain.
  • Diaz-Martin J; Institute of Biomedicine of Sevilla, Sevilla, Spain.
  • Biscuola M; Department of Pathology, University Hospital Virgen del Rocío, Sevilla, Spain; CIBERONC, Madrid, Spain.
  • Taron M; Institute of Biomedicine of Sevilla, Sevilla, Spain.
  • Collini P; Soft Tissue and Bone Pathology, Histopathology and Pediatric Pathology Unit, Department of Diagnostic Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Ranchere-Vince D; Department of Pathology, Centre Léon Bérard, Université Claude Bernard Lyon, Lyon, France.
  • Garcia Del Muro X; Catalan Institute of Oncology, Barcelona, Spain; Institut d'Investigació Biomédica de Bellvitge, University of Barcelona, Barcelona, Spain.
  • Grignani G; Sarcoma Unit, Division of Medical Oncology, Candiolo Cancer Institute, FPO, IRCCS, Candiolo, Italy.
  • Dumont S; Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France.
  • Martinez-Trufero J; Department of Medical Oncology, University Hospital Miguel Servet, Zaragoza, Spain.
  • Palmerini E; Chemotherapy Unit, Istituto Ortopedico Rizzoli, Bologna, Italy.
  • Hindi N; Department of Medical Oncology, University Hospital Virgen del Rocío, Sevilla, Spain; Institute of Biomedicine of Sevilla, Sevilla, Spain.
  • Sebio A; Department of Medical Oncology, Sant Pau Hospital, Barcelona, Spain.
  • Dopazo J; Clinical Bioinformatics Area, Fundación Progreso y Salud, University Hospital Virgen del Rocío, Sevilla, Spain.
  • Dei Tos AP; Department of Medicine, University of Padua School of Medicine, Padua, Italy.
  • LeCesne A; Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France.
  • Blay JY; Department of Medical Oncology, Centre Léon Bérard, Université Claude Bernard Lyon, Lyon, France.
  • Cruz J; Department of Medical Oncology, University Hospital of Canarias, Tenerife, Spain.
Lancet Oncol ; 20(1): 134-144, 2019 01.
Article em En | MEDLINE | ID: mdl-30578023

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirimidinas / Neoplasias de Tecidos Moles / Sulfonamidas / Inibidores da Angiogênese / Tumores Fibrosos Solitários / Antineoplásicos Tipo de estudo: Clinical_trials / Observational_studies / Systematic_reviews Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirimidinas / Neoplasias de Tecidos Moles / Sulfonamidas / Inibidores da Angiogênese / Tumores Fibrosos Solitários / Antineoplásicos Tipo de estudo: Clinical_trials / Observational_studies / Systematic_reviews Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article